Alpha-antitrypsin: PPL began Phase I testing

PPL Therapeutics plc (LSE:PTH), Edinburgh, Scotland
Product:

Read the full 75 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE